Longevity to merge with THPlasma in a $79m deal.

Longevity, a company focused on human longevity and healthy aging, agreed to merge with THPlasma, a plasma donation centers operator, in a $79m deal. “I am thrilled to announce our merger with Longevity, a transformative step expected to supercharge our growth by unlocking access to public markets and future M&A opportunities. Our teams are strategically aligned to fuel innovation, accelerate scale, and deliver value across the board. This is an exciting milestone in our journey, and I look forward to the incredible opportunities ahead as we build the future together through our disciplined execution approach,” George Chi, THPlasma Founder and CEO.